1887

Abstract

is a major cause of invasive disease of young children in low- and middle-income countries. In southern India, pneumococcal conjugate vaccines (PCVs) that can prevent invasive pneumococcal disease began to be used more frequently after 2015. To characterize pneumococcal evolution during the early time period of PCV uptake in southern India, genomes were sequenced and selected characteristics were determined for 402 invasive isolates collected from children <5 years of age during routine surveillance from 1991 to 2020. Overall, the prevalence and diversity of vaccine type (VT) and non-vaccine type (NVT) isolates did not significantly change post-uptake of PCV. Individually, serotype 1 and global pneumococcal sequence cluster (GPSC or strain lineage) 2 significantly decreased, whereas serotypes 6B, 9V and 19A and GPSCs 1, 6, 10 and 23 significantly increased in proportion post-uptake of PCV. Resistance determinants to penicillin, erythromycin, co-trimoxazole, fluoroquinolones and tetracycline, and multidrug resistance significantly increased in proportion post-uptake of PCV and especially among VT isolates. Co-trimoxazole resistance determinants were common pre- and post-uptake of PCV (85 and 93 %, respectively) and experienced the highest rates of recombination in the genome. Accessory gene frequencies were seen to be changing by small amounts across the frequency spectrum specifically among VT isolates, with the largest changes linked to antimicrobial resistance determinants. In summary, these results indicate that as of 2020 this pneumococcal population was not yet approaching a PCV-induced equilibrium and they highlight changes related to antimicrobial resistance. Augmenting PCV coverage and prudent use of antimicrobials are needed to counter invasive pneumococcal disease in this region.

Funding
This study was supported by the:
  • Pfizer (Award 57039923)
    • Principle Award Recipient: VeeraraghavanBalaji
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.001191
2024-02-05
2024-05-20
Loading full text...

Full text loading...

/deliver/fulltext/mgen/10/2/mgen001191.html?itemId=/content/journal/mgen/10.1099/mgen.0.001191&mimeType=html&fmt=ahah

References

  1. Troeger C, Forouzanfar M, Rao PC, Khalil I, Brown A et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis 2017; 17:1133–1161 [View Article] [PubMed]
    [Google Scholar]
  2. Wahl B, O’Brien KL, Greenbaum A, Majumder A, Liu L et al. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15. Lancet Glob Health 2018; 6:e744–e757 [View Article] [PubMed]
    [Google Scholar]
  3. Farooqui H, Jit M, Heymann DL, Zodpey S. Burden of severe pneumonia, pneumococcal pneumonia and pneumonia deaths in Indian states: modelling based estimates. PLoS One 2015; 10:e0129191 [View Article] [PubMed]
    [Google Scholar]
  4. Immunization Division National Operational Guidelines for PCV Introduction Ministry of Health & Family Welfare, Government of India; 2021
    [Google Scholar]
  5. Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA et al. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med 2013; 10:e1001517 [View Article] [PubMed]
    [Google Scholar]
  6. Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010; 201:32–41 [View Article] [PubMed]
    [Google Scholar]
  7. Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2007; 196:1346–1354 [View Article] [PubMed]
    [Google Scholar]
  8. Flasche S, Van Hoek AJ, Sheasby E, Waight P, Andrews N et al. Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study. PLoS Med 2011; 8:e1001017 [View Article] [PubMed]
    [Google Scholar]
  9. O’Brien KL, Millar EV, Zell ER, Bronsdon M, Weatherholtz R et al. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. J Infect Dis 2007; 196:1211–1220 [View Article] [PubMed]
    [Google Scholar]
  10. Chochua S, Metcalf BJ, Li Z, Walker H, Tran T et al. Invasive serotype 35B pneumococci including an expanding serotype switch lineage, United States, 2015-2016. Emerg Infect Dis 2017; 23:922–930 [View Article] [PubMed]
    [Google Scholar]
  11. Lo SW, Gladstone RA, van Tonder AJ, Lees JA, du Plessis M et al. Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study. Lancet Infect Dis 2019; 19:759–769 [View Article] [PubMed]
    [Google Scholar]
  12. Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 2006; 354:1455–1463 [View Article] [PubMed]
    [Google Scholar]
  13. Gertz RE, Li Z, Pimenta FC, Jackson D, Juni BA et al. Increased penicillin nonsusceptibility of nonvaccine-serotype invasive pneumococci other than serotypes 19A and 6A in post-7-valent conjugate vaccine era. J Infect Dis 2010; 201:770–775 [View Article] [PubMed]
    [Google Scholar]
  14. Corander J, Fraser C, Gutmann MU, Arnold B, Hanage WP et al. Frequency-dependent selection in vaccine-associated pneumococcal population dynamics. Nat Ecol Evol 2017; 1:1950–1960 [View Article] [PubMed]
    [Google Scholar]
  15. Azarian T, Grant LR, Arnold BJ, Hammitt LL, Reid R et al. The impact of serotype-specific vaccination on phylodynamic parameters of Streptococcus pneumoniae and the pneumococcal pan-genome. PLoS Pathog 2018; 14:e1006966 [View Article] [PubMed]
    [Google Scholar]
  16. Watkins ER, Penman BS, Lourenço J, Buckee CO, Maiden MCJ et al. Vaccination drives changes in metabolic and virulence profiles of Streptococcus pneumoniae. PLoS Pathog 2015; 11:e1005034 [View Article] [PubMed]
    [Google Scholar]
  17. Lourenço J, Watkins ER, Obolski U, Peacock SJ, Morris C et al. Lineage structure of Streptococcus pneumoniae may be driven by immune selection on the groEL heat-shock protein. Sci Rep 2017; 7:9023 [View Article] [PubMed]
    [Google Scholar]
  18. Kolhapure S, Yewale V, Agrawal A, Krishnappa P, Soumahoro L. Invasive Pneumococcal Disease burden and PCV coverage in children under five in Southeast Asia: implications for India. J Infect Dev Ctries 2021; 15:749–760 [View Article] [PubMed]
    [Google Scholar]
  19. Chaguza C, Senghore M, Bojang E, Gladstone RA, Lo SW et al. Within-host microevolution of Streptococcus pneumoniae is rapid and adaptive during natural colonisation. Nat Commun 2020; 11:3442 [View Article] [PubMed]
    [Google Scholar]
  20. Bradshaw JL, Rafiqullah IM, Robinson DA, McDaniel LS. Transformation of nonencapsulated Streptococcus pneumoniae during systemic infection. Sci Rep 2020; 10:18932 [View Article] [PubMed]
    [Google Scholar]
  21. Nagaraj G, Govindan V, Ganaie F, Venkatesha VT, Hawkins PA et al. Streptococcus pneumoniae genomic datasets from an Indian population describing pre-vaccine evolutionary epidemiology using a whole genome sequencing approach. Microb Genom 2021; 7:000645 [View Article] [PubMed]
    [Google Scholar]
  22. Verghese VP, Friberg IK, Cherian T, Raghupathy P, Balaji V et al. Community effect of Haemophilus influenzae type b vaccination in India. Pediatr Infect Dis J 2009; 28:738–740 [View Article] [PubMed]
    [Google Scholar]
  23. SourceForge [Internet]. BBMap; 2022 https://sourceforge.net/projects/bbmap/ accessed 5 October 2023
  24. Prjibelski A, Antipov D, Meleshko D, Lapidus A, Korobeynikov A. Using SPAdes De Novo assembler. Curr Protoc Bioinform 2020; 70:e102 [View Article] [PubMed]
    [Google Scholar]
  25. Parks DH, Imelfort M, Skennerton CT, Hugenholtz P, Tyson GW. CheckM: assessing the quality of microbial genomes recovered from isolates, single cells, and metagenomes. Genome Res 2015; 25:1043–1055 [View Article] [PubMed]
    [Google Scholar]
  26. Epping L, van Tonder AJ, Gladstone RA. The Global Pneumococcal Sequencing Consortium Bentley SD et al. SeroBA: rapid high-throughput serotyping of Streptococcus pneumoniae from whole genome sequence data. Microb Genom 2018; 4:e000186 [View Article] [PubMed]
    [Google Scholar]
  27. Lees JA, Harris SR, Tonkin-Hill G, Gladstone RA, Lo SW et al. Fast and flexible bacterial genomic epidemiology with PopPUNK. Genome Res 2019; 29:304–316 [View Article] [PubMed]
    [Google Scholar]
  28. Seemann T. tseemann/mlst [Internet]; 2021 https://github.com/tseemann/mlst accessed 8 June 2021
  29. Li Y, Metcalf BJ, Chochua S, Li Z, Gertz RE et al. Validation of β-lactam minimum inhibitory concentration predictions for pneumococcal isolates with newly encountered penicillin binding protein (PBP) sequences. BMC Genomics 2017; 18:621 [View Article] [PubMed]
    [Google Scholar]
  30. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25:1754–1760 [View Article] [PubMed]
    [Google Scholar]
  31. Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, Del Angel G et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinformatics 2013; 43:11 [View Article] [PubMed]
    [Google Scholar]
  32. Challagundla L, Luo X, Tickler IA, Didelot X, Coleman DC et al. Range expansion and the origin of USA300 North American epidemic methicillin-resistant Staphylococcus aureus. mBio 2018; 9:e02016-17 [View Article] [PubMed]
    [Google Scholar]
  33. Guindon S, Dufayard J-F, Lefort V, Anisimova M, Hordijk W et al. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol 2010; 59:307–321 [View Article] [PubMed]
    [Google Scholar]
  34. Hilty M, Wüthrich D, Salter SJ, Engel H, Campbell S et al. Global phylogenomic analysis of nonencapsulated Streptococcus pneumoniae reveals a deep-branching classic lineage that is distinct from multiple sporadic lineages. Genome Biol Evol 2014; 6:3281–3294 [View Article] [PubMed]
    [Google Scholar]
  35. Didelot X, Wilson DJ. ClonalFrameML: efficient inference of recombination in whole bacterial genomes. PLoS Comput Biol 2015; 11:e1004041 [View Article] [PubMed]
    [Google Scholar]
  36. Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 2010; 26:841–842 [View Article] [PubMed]
    [Google Scholar]
  37. Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics 2014; 30:2068–2069 [View Article] [PubMed]
    [Google Scholar]
  38. Hyatt D. Prodigal [Internet]; 2023 https://github.com/hyattpd/Prodigal accessed 5 October 2023
  39. Page AJ, Cummins CA, Hunt M, Wong VK, Reuter S et al. Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics 2015; 31:3691–3693 [View Article] [PubMed]
    [Google Scholar]
  40. Grundmann H, Hori S, Tanner G. Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms. J Clin Microbiol 2001; 39:4190–4192 [View Article] [PubMed]
    [Google Scholar]
  41. R: The R Project for Statistical Computing [Internet]. n.d https://www.r-project.org/ accessed 22 May 2021
  42. Winter DJ. mmod: an R library for the calculation of population differentiation statistics. Mol Ecol Resour 2012; 12:1158–1160 [View Article] [PubMed]
    [Google Scholar]
  43. Jost L. G(ST) and its relatives do not measure differentiation. Mol Ecol 2008; 17:4015–4026 [View Article] [PubMed]
    [Google Scholar]
  44. Cornick JE, Harris SR, Parry CM, Moore MJ, Jassi C et al. Genomic identification of a novel co-trimoxazole resistance genotype and its prevalence amongst Streptococcus pneumoniae in Malawi. J Antimicrob Chemother 2014; 69:368–374 [View Article] [PubMed]
    [Google Scholar]
  45. Minnen A, Attaiech L, Thon M, Gruber S, Veening JW. SMC is recruited to oriC by ParB and promotes chromosome segregation in Streptococcus pneumoniae. Mol Microbiol 2011; 81:676–688 [View Article] [PubMed]
    [Google Scholar]
  46. Azarian T, Martinez PP, Arnold BJ, Qiu X, Grant LR et al. Frequency-dependent selection can forecast evolution in Streptococcus pneumoniae. PLoS Biol 2020; 18:e3000878 [View Article] [PubMed]
    [Google Scholar]
  47. India | ViewHub [Internet]. n.d https://view-hub.org/map/country/ind accessed 15 September 2023
  48. Adamu AL, Ojal J, Abubakar IA, Odeyemi KA, Bello MM et al. The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria. Nat Commun 2023; 14:2666 [View Article] [PubMed]
    [Google Scholar]
  49. Varghese R, Neeravi A, Subramanian N, Pavithra B, Kavipriya A et al. Clonal similarities and sequence-type diversity of invasive and carriage Streptococcus pneumoniae in India among children under 5 years. Indian J Med Microbiol 2019; 37:358–362 [View Article] [PubMed]
    [Google Scholar]
  50. Lewnard JA, Hanage WP. Making sense of differences in pneumococcal serotype replacement. Lancet Infect Dis 2019; 19:e213–e220 [View Article] [PubMed]
    [Google Scholar]
  51. Huang SS, Hinrichsen VL, Stevenson AE, Rifas-Shiman SL, Kleinman K et al. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics 2009; 124:e1–11 [View Article] [PubMed]
    [Google Scholar]
  52. Ndlangisa KM, du Plessis M, Lo S, de Gouveia L, Chaguza C et al. A Streptococcus pneumoniae lineage usually associated with pneumococcal conjugate vaccine (PCV) serotypes is the most common cause of serotype 35B invasive disease in South Africa, following routine use of PCV. Microb Genom 2022; 8:000746 [View Article] [PubMed]
    [Google Scholar]
  53. Harboe ZB, Thomsen RW, Riis A, Valentiner-Branth P, Christensen JJ et al. Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med 2009; 6:e1000081 [View Article] [PubMed]
    [Google Scholar]
  54. Watkins ER, Kalizang’Oma A, Gori A, Gupta S, Heyderman RS. Factors affecting antimicrobial resistance in Streptococcus pneumoniae following vaccination introduction. Trends Microbiol 2022; 30:1135–1145 [View Article] [PubMed]
    [Google Scholar]
  55. Kandasamy R, Lo S, Gurung M, Carter MJ, Gladstone R et al. Effect of childhood vaccination and antibiotic use on pneumococcal populations and genome-wide associations with disease among children in Nepal: an observational study. Lancet Microbe 2022; 3:e503–e511 [View Article] [PubMed]
    [Google Scholar]
  56. Ahmed I, Rabbi MB, Sultana S. Antibiotic resistance in Bangladesh: a systematic review. Int J Infect Dis 2019; 80:54–61 [View Article] [PubMed]
    [Google Scholar]
  57. Chewapreecha C, Harris SR, Croucher NJ, Turner C, Marttinen P et al. Dense genomic sampling identifies highways of pneumococcal recombination. Nat Genet 2014; 46:305–309 [View Article] [PubMed]
    [Google Scholar]
  58. Croucher NJ, Chewapreecha C, Hanage WP, Harris SR, McGee L et al. Evidence for soft selective sweeps in the evolution of pneumococcal multidrug resistance and vaccine escape. Genome Biol Evol 2014; 6:1589–1602 [View Article] [PubMed]
    [Google Scholar]
  59. Lehtinen S, Chewapreecha C, Lees J, Hanage WP, Lipsitch M et al. Horizontal gene transfer rate is not the primary determinant of observed antibiotic resistance frequencies in Streptococcus pneumoniae. Sci Adv 2020; 6:eaaz6137 [View Article] [PubMed]
    [Google Scholar]
  60. Haasum Y, Ström K, Wehelie R, Luna V, Roberts MC et al. Amino acid repetitions in the dihydropteroate synthase of Streptococcus pneumoniae lead to sulfonamide resistance with limited effects on substrate K(m). Antimicrob Agents Chemother 2001; 45:805–809 [View Article] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/mgen/10.1099/mgen.0.001191
Loading
/content/journal/mgen/10.1099/mgen.0.001191
Loading

Data & Media loading...

Supplements

Supplementary material 1

EXCEL

Supplementary material 2

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error